Abstract:Tetrandrine has a variety of anti-tumor effects including against or reversal of tumor chemoresistance, but its mechanism of against tumor chemoresistance is still unclear. Therefore, the analytical method of network pharmacology and molecular docking was used to investigate the mechanism by which tetrandrine acts in tumor chemoresistance. We used public databases (PubChem, SwissADEM, SwissTargetPrediction) to obtain the physicochemical information and targets of tetrandrine, and used gene databases (GeneCards and OMIM) to collected disease targets, respectively. The intersection targets of disease and drug were analyzed by RStudio. We built protein-protein interaction network through the STRING database, and used Cystoscope to screen out hub genes. GO and KEGG pathway enrichment analysis were analyzed by Metascape database and RStudio. "Component-target-pathway" network was erected by Cystoscope. Ultimately, the key targets were chosen to dock with tetrandrine via molecular docking to verify network analysis results. 29 common targets were screened out through intersection. AKT1, PIK3CA, PIK3CB, PIK3CG, JAK2, IGF1R, KDR, SRC and MTOR were the core targets. KEGG pathway enrichment mainly included PI3K-AKT signaling pathway, EGFR tyrosine kinase inhibitor resistance, and Rap1 signaling pathway. Molecular docking indicated that the configuration of protein binding of ligand is stable. In conclusion, the against tumor chemoresistance effect of tetrandrine has the characteristics of multiple targets and multiple pathways, and the prediction of network pharmacology and molecular docking indicated that MTOR, SRC, PIK3CA were the key targets of tetrandrine in tumor chemoresistance, which provides a scientific basis for subsequent research on its anti-tumor chemoresistance mechanism.

Advanced Progress on the Effect and Mechanism of Tetrandrine

Progress on structural modification of Tetrandrine with wide range of pharmacological activities

Progress of Research on Anti-tumor Effect of Tetrandrine

Advancement in Research on Anti-tumor Effect of Tetrandrine

Insights on Exploring the Therapeutic Potential and Structural Modification of Tetrandrine.

Advances in nano‐preparations for improving tetrandrine solubility and bioavailability

Tetrandrine, A Chinese Plant-Derived Alkaloid, Is A Potential Candidate For Cancer Chemotherapy

Dissection of the antitumor mechanism of tetrandrine based on metabolite profiling and network pharmacology

Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells

Pharmacology of Tetrandrine and Its Therapeutic Use in Digestive Diseases.

Tetrandrine Suppresses Cervical Cancer Growth by Inducing Apoptosis in Vitro and in Vivo

Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer

Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer

Integrated Network Pharmacology And Molecular Docking To Reveal The Mechanism Of Tetrandrine In Tumor Chemoresistance

Tetrandrine Inhibits the Wnt/β-Catenin Signalling Pathway and Alleviates Osteoarthritis: an in Vitro and in Vivo Study

Mechanism of Tetrandrine in Combination with Droloxifen to Reverse Multidrug Resistance in Leukemia

TGF-β1/PTEN/PI3K Signaling Plays a Critical Role in the Anti-Proliferation Effect of Tetrandrine in Human Colon Cancer Cells.

Discovery of tetrandrine derivatives as tumor migration, invasion and angiogenesis inhibitors

Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species

Effect of tetrandrine on murine hemangioendothelioma cell and its molecular mechanisms

Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives As Potential Anti-Cancer Agents